Skip to main
SLP
SLP logo

Simulations Plus (SLP) Stock Forecast & Price Target

Simulations Plus (SLP) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 40%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Simulations Plus Inc. reported total revenue of $20.4 million for the third fiscal quarter (F3Q), which met consensus expectations and exceeded its guidance range, indicating stable financial performance. The company anticipates a potential acceleration in organic revenue growth towards high-single digits in FY26, driven by the recent Proficiency acquisition, which may mitigate the impact of customer cancellations. With a robust revenue mix of approximately 55-60% from software and 40-45% from services, the company is well-positioned within the pharmaceutical research and consulting sectors.

Bears say

Simulations Plus Inc. faces significant challenges in the biopharma end market due to its concentrated customer base and exposure to the biotech sector, leading to expectations of continued weak customer demand in the near-to-middle term. In its most recent financial results, the company reported third-quarter software revenue of $12.6 million, which fell short of the $13.6 million consensus estimate, despite service revenue exceeding expectations. Additionally, elevated SG&A expenses of $8.8 million, which were above the consensus of $7.8 million, further complicate the financial outlook amid a landscape lacking signs of recovery in biotech markets.

Simulations Plus (SLP) has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 40% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Simulations Plus and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Simulations Plus (SLP) Forecast

Analysts have given Simulations Plus (SLP) a Buy based on their latest research and market trends.

According to 5 analysts, Simulations Plus (SLP) has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $24.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $24.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Simulations Plus (SLP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.